EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparing highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone in poor ovarian reserve patients undergoing intracytoplasmic sperm injection

Dilay Gok Korucu iD, Humeyra Akgun iD, Mahmut Sami Tutar iD, Sukran Doğru iD, Oguzhan Gunenc iD

Česká gynekologie · 2024

DOI: 10.48095/cccg2024469 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Česká gynekologie, 2024. Verfasst von Dilay Gok Korucu und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Sperm Injections, Intracytoplasmic, Menotropins, Ovarian Reserve, Follicle Stimulating Hormone.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to compare highly purified human menopausal gonadotropin (hp-hMG) and recombinant follicle stimulating hormone (rFSH) in short antagonist in vitro fertilization (IVF) cycles of patients with poor ovarian reserve (POR). Limited research exists on this comparison in short antagonist cycles for this patient group. Materials and methods: This retrospective cohort study involved 165 POR patients aged 18–45 years who underwent IVF between 2018 and 2022. Patients were divided into two groups based on their GnRH antagonist protocol: hp-hMG (group 1 = 72) and rFSH (group 2 = 93). We compared pregnancy outcomes, number of oocytes collected, mature oocytes retrieved, mean fertilized oocytes, top quality embryos transferred, and serum estradiol (E2) and progesterone (P) levels on human chorionic gonadotropin (hCG) administration day.

Results

No significant differences were found in E2 and P levels on hCG trigger day, endometrial thickness on transfer day, stimulation duration, total oocyte number, and mature oocyte number (P > 0.05). The total gonadotropin dose was significantly higher in the rFSH group (P < 0.001). The number of top-quality embryos transferred and clinical pregnancy and live birth rates did not diff er significantly between groups (P = 0.320; P = 0.310; P = 0.652; and P = 0.662, resp.).

Conclusion

Neither hp-hMG nor rFSH showed superiority in patients with POR, indicating similar effectiveness in this population. Key words: highly purified human menopausal gonadotropin – in vitro fertilization – live birth – poor ovarian reserve – recombinant follicle stimulating hormone

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sperm Injections, IntracytoplasmicMenotropinsOvarian ReserveFollicle Stimulating HormoneOvulation InductionHumansFemaleAdultPregnancyRetrospective StudiesRecombinant ProteinsPregnancy RateEstradiolMiddle AgedYoung AdultAdolescentEmbryo TransferProgesteronePregnancy OutcomeGonadotropin-Releasing HormoneFertilization in Vitro

Stichwörter der Autor:innen

In vitro fertilizationhighly purified human menopausal gonadotropinin vitro fertilizationlive birthpoor ovarian reserverecombinant follicle stimulating hormone

Substanzen

MenotropinsFollicle Stimulating HormoneRecombinant ProteinsEstradiolProgesteroneGonadotropin-Releasing Hormone

Autor:innen und Institutionen

ORCID-Profile: Dilay Gok Korucu, Humeyra Akgun, Mahmut Sami Tutar, Sukran Doğru, Oguzhan Gunenc

Zitieren

APA

Korucu, D. G., Akgun, H., Tutar, M. S., Doğru, S., & Gunenc, O. (2024). Comparing highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone in poor ovarian reserve patients undergoing intracytoplasmic sperm injection. Česká gynekologie. https://doi.org/10.48095/cccg2024469

Vancouver

Korucu DG, Akgun H, Tutar MS, Doğru S, Gunenc O. Comparing highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone in poor ovarian reserve patients undergoing intracytoplasmic sperm injection. Česká gynekologie. 2024. doi:10.48095/cccg2024469

BibTeX
@article{Korucu2024,
  author = {Korucu, Dilay Gok and Akgun, Humeyra and Tutar, Mahmut Sami and Doğru, Sukran and Gunenc, Oguzhan},
  title = {Comparing highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone in poor ovarian reserve patients undergoing intracytoplasmic sperm injection},
  journal = {Česká gynekologie},
  year = {2024},
  doi = {10.48095/cccg2024469}
}
Kostenlos starten →